BSIM THERAPEUTICS
BSIM’s mission is to deliver quality drug candidates with high capital efficiency against transthyretin-mediated amyloidosis, including clinical manifestations and related pathologies that represent important and unmet medical needs. Our products are directed to a group of rare, hereditary and fatal pathologies commonly addressed to as Transthyretin Amyloidoses (hATTR). We are developing drug candidates that fit within distinct target-product profiles for the treatment of a broader range of hATTR manifestations, including central nervous system symptoms (e.g. seizures, stroke-like events, progressive dementia) and oculopathy (e.g. vitreous opacities, glaucoma).
BSIM THERAPEUTICS
Industry:
Biotechnology Pharmaceutical
Founded:
2011-01-01
Address:
Coimbra, Coimbra, Portugal
Country:
Portugal
Website Url:
http://www.bsimtx.com
Total Employee:
1+
Status:
Active
Contact:
+351 239 405 201
Email Addresses:
[email protected]
Total Funding:
2.55 M EUR
Technology used in webpage:
SPF Google Maps GStatic Google Static Content Google Maps API SpamExperts PTisp
Current Advisors List
Current Employees Featured
Founder
Investors List
Portugal Ventures
Portugal Ventures investment in Seed Round - BSIM Therapeutics
a2b SGPS
a2b SGPS investment in Pre Seed Round - BSIM Therapeutics
Bluepharma – Indústria Farmacêutica
Bluepharma – Indústria Farmacêutica investment in Pre Seed Round - BSIM Therapeutics
Official Site Inspections
http://www.bsimtx.com
- Host name: 206.189.118.199
- IP address: 206.189.118.199
- Location: London United Kingdom
- Latitude: 51.5353
- Longitude: -0.6658
- Timezone: Europe/London
- Postal: SL1
